Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

338.54 UNCHANGED
Delayed Quote Updated: 7:00 PM EST, Nov 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
News headline image
What to expect from Charles River Laboratories’s (CRL) Q3 earnings
Lab services company Charles River Laboratories (NYSE:CRL) will be announcing earnings results this Wednesday before the bell. Here’s what to look for. Charl... 
Via StockStory
Topics Artificial Intelligence
News headline image
Charles River Leverages Virtual Control Groups in GLP Studies
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
2 healthcare stocks to keep an eye on and 1 that underwhelm
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry... 
Via StockStory
News headline image
Charles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential Assessment
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
3 mid-cap stocks walking a fine line
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man... 
Via StockStory
S&P 500 Top Movers: Oct. 21, 2026 US Session ↗
Via Chartmill
Topics Stocks
S&P 500 Top Movers on Oct. 21, 2026: Supermicro Leads Gainers, Dexcom Leads Losers ↗
Via Chartmill
Topics Stocks
S&P 500 Top Movers: EFX and HAS Lead Today's Gainers, GM and DVA Fall ↗
Via Chartmill
Topics Stocks
S&P 500 Top Movers: Gainers and Losers From Today's US Session ↗
Via Chartmill
Topics Stocks
News headline image
Drug Development Inputs & Services Stocks Q2 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including Charles River Laboratories (NY... 
Via StockStory
News headline image
Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development
From Charles River Laboratories
Via Business Wire
News headline image
1 S&P 500 Stock to Target This Week and 2 We Question
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec... 
Via StockStory
Topics Fraud Stocks
News headline image
Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Stay informed with the top movers within the S&P500 index on Thursday. ↗
Via Chartmill
News headline image
Charles River and Autolomous Partner to Transform Laboratory Execution Systems
From Charles River Laboratories International, Inc.
Via Business Wire
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
Which S&P500 stocks are moving on Monday? ↗
Via Chartmill
News headline image
Charles River Targets 5%-7% Growth, $300M Savings in 2030 Plan ↗
Charles River Laboratories International (NYSE:CRL) outlined a strategy to accelerate growth, expand margins and modernize its operations during its 2026 Investor Day, setting financial targets through... 
Via MarketBeat
Topics Artificial Intelligence
Discover which S&P500 stocks are making waves on Thursday. ↗
Via Chartmill
News headline image
Why Charles River Laboratories (CRL) Stock Is Up Today
What Happened? Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 5.7% in the afternoon session after the company outlined long-term... 
Via StockStory
Topics Artificial Intelligence
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Charles River Highlights Refreshed Strategic Vision to Drive Profitable Growth and Long-Term Value Creation at 2026 Investor Day
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
3 Unpopular Stocks Walking a Fine Line
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea... 
Via StockStory
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
Why Charles River Laboratories (CRL) Stock Is Trading Up Today
What Happened? Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 3.6% in the afternoon session after the company announced the laun... 
Via StockStory
News headline image
Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking Timelines
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
3 Reasons to Sell CRL and 1 Stock to Buy Instead
What a fantastic six months it’s been for Charles River Laboratories. Shares of the company have skyrocketed 79.5%, hitting $272.74. This was partly thanks t... 
Via StockStory
News headline image
Charles River Laboratories to Present at Morgan Stanley and Baird Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Wall Street Is Now Backing the Clarity Act. Here's the Most Likely Scenario for What Happens Next With Crypto. ↗
Even if there's no clarity on the Clarity Act, Coinbase and Circle could still power higher over the next 12 months. 
Via The Motley Fool
Topics Government
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.